elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38669170-372F1C6F-9FE3-4638-A43E-84B8AA70718A
Q38669170-372F1C6F-9FE3-4638-A43E-84B8AA70718A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38669170-372F1C6F-9FE3-4638-A43E-84B8AA70718A
Glycogen phosphorylase inhibitors: a patent review (2013 - 2015).
P2860
Q38669170-372F1C6F-9FE3-4638-A43E-84B8AA70718A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38669170-372F1C6F-9FE3-4638-A43E-84B8AA70718A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0bb5de20dc496c1152de9f6b01765b011e134e62
P2860
Discovery of tofogliflozin, a novel C-arylglucoside with an O-spiroketal ring system, as a highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.